These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36323232)

  • 1. Targeting PDAC metabolism: Environment determines what has GOT2 give.
    Newsom OJ; Sullivan LB
    Cell Metab; 2022 Nov; 34(11):1617-1619. PubMed ID: 36323232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial glutamine metabolism via GOT2 supports pancreatic cancer growth through senescence inhibition.
    Yang S; Hwang S; Kim M; Seo SB; Lee JH; Jeong SM
    Cell Death Dis; 2018 Jan; 9(2):55. PubMed ID: 29352139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GOT2 consider the tumor microenvironment.
    Do BT; Vander Heiden MG
    Trends Cancer; 2022 Nov; 8(11):884-886. PubMed ID: 36153305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors.
    Reyes-Castellanos G; Abdel Hadi N; Carrier A
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context.
    Kerk SA; Lin L; Myers AL; Sutton DJ; Andren A; Sajjakulnukit P; Zhang L; Zhang Y; Jiménez JA; Nelson BS; Chen B; Robinson A; Thurston G; Kemp SB; Steele NG; Hoffman MT; Wen HJ; Long D; Ackenhusen SE; Ramos J; Gao X; Nwosu ZC; Galban S; Halbrook CJ; Lombard DB; Piwnica-Worms DR; Ying H; Pasca di Magliano M; Crawford HC; Shah YM; Lyssiotis CA
    Elife; 2022 Jul; 11():. PubMed ID: 35815941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer.
    Sasaki K; Takano S; Tomizawa S; Miyahara Y; Furukawa K; Takayashiki T; Kuboki S; Takada M; Ohtsuka M
    J Exp Clin Cancer Res; 2021 Jun; 40(1):212. PubMed ID: 34167573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cancer Cell-Intrinsic GOT2-PPARδ Axis Suppresses Antitumor Immunity.
    Abrego J; Sanford-Crane H; Oon C; Xiao X; Betts CB; Sun D; Nagarajan S; Diaz L; Sandborg H; Bhattacharyya S; Xia Z; Coussens LM; Tontonoz P; Sherman MH
    Cancer Discov; 2022 Oct; 12(10):2414-2433. PubMed ID: 35894778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing metabolic dependencies in pancreatic cancers.
    Encarnación-Rosado J; Kimmelman AC
    Nat Rev Gastroenterol Hepatol; 2021 Jul; 18(7):482-492. PubMed ID: 33742165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
    Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG
    Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
    Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
    Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting cancer cell metabolism in pancreatic adenocarcinoma.
    Cohen R; Neuzillet C; Tijeras-Raballand A; Faivre S; de Gramont A; Raymond E
    Oncotarget; 2015 Jul; 6(19):16832-47. PubMed ID: 26164081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer.
    Lodestijn SC; Miedema DM; Lenos KJ; Nijman LE; Belt SC; El Makrini K; Lecca MC; Waasdorp C; van den Bosch T; Bijlsma MF; Vermeulen L
    Cell Rep; 2021 Oct; 37(3):109852. PubMed ID: 34686335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells.
    Wiley SZ; Sriram K; Liang W; Chang SE; French R; McCann T; Sicklick J; Nishihara H; Lowy AM; Insel PA
    FASEB J; 2018 Mar; 32(3):1170-1183. PubMed ID: 29092903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
    Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
    Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
    Halbrook CJ; Lyssiotis CA
    Cancer Cell; 2017 Jan; 31(1):5-19. PubMed ID: 28073003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma.
    Tuerhong A; Xu J; Shi S; Tan Z; Meng Q; Hua J; Liu J; Zhang B; Wang W; Yu X; Liang C
    Cell Mol Life Sci; 2021 Jul; 78(14):5505-5526. PubMed ID: 34131808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth.
    Yang H; Zhou L; Shi Q; Zhao Y; Lin H; Zhang M; Zhao S; Yang Y; Ling ZQ; Guan KL; Xiong Y; Ye D
    EMBO J; 2015 Apr; 34(8):1110-25. PubMed ID: 25755250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
    Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q
    Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766
    [No Abstract]   [Full Text] [Related]  

  • 20. Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma.
    Lau AN; Li Z; Danai LV; Westermark AM; Darnell AM; Ferreira R; Gocheva V; Sivanand S; Lien EC; Sapp KM; Mayers JR; Biffi G; Chin CR; Davidson SM; Tuveson DA; Jacks T; Matheson NJ; Yilmaz O; Vander Heiden MG
    Elife; 2020 Jul; 9():. PubMed ID: 32648540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.